Notice Of Assignment Of Assets For Key Products In The U.S. Within Sumitomo Pharma Group
26/06/2025 09:31
Sumitomo Pharma Co Ltd 4506.T: SUMITOMO PHARMA CO LTD - NOTICE OF ASSIGNMENT OF ASSETS FOR KEY PRODUCTS IN THE U.S. WITHIN SUMITOMO PHARMA GROUP Source text: ID:nTSrz7a5a7 Further company coverage: 4506.T
Recent news on Sumitomo Pharma
See all newsSumitomo Pharma America Announces First Patient Receives Treatment In Phase 1/2A Study For Investigational Therapy Dsp-3077 For Retinitis Pigmentosa
Regarding A Report Concerning Sumitomo Pharma ( Company's Views On Gcr August 7 Report)
Brief: Sumitomo Pharma - Gotham City Research's August 3 Report Contains Numerous Statements That Are Clearly Inconsistent With Facts
Brief: Gotham City Research Holds Short Positions In Sumitomo Chemical And Sumitomo Pharmaceutical
Table: Sumitomo Pharma -Q1 group results (IFRS)